Clinical Trial Update: Loose-dose Combination of Acarbose and Metformin for T2DM in Metformin-failure Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating a loose-dose combination of acarbose and metformin in type 2 diabetes patients failing metformin therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose and Metformin loose-dose combination (acarbose / metformin)

Snippet

Sponsor: Bayer | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED